Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets
A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutat...
Saved in:
Published in | Antiviral research Vol. 54; no. 2; pp. 99 - 111 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
01.05.2002
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (
n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naı̈ve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits. |
---|---|
AbstractList | A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (
n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naı̈ve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits. A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naïve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits.A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naïve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits. A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naïve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits. A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naive contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits. |
Author | Herlocher, M.L Elias, S Roberts, N Monto, A.S Carr, J Ives, J Truscon, R |
Author_xml | – sequence: 1 givenname: M.L surname: Herlocher fullname: Herlocher, M.L email: louise@umich.edu organization: Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA – sequence: 2 givenname: J surname: Carr fullname: Carr, J organization: Viral Diseases, Roche Discovery Welwyn, 40 Broadwater Road, Welwn Garden City, Herts. AL6 3AY, UK – sequence: 3 givenname: J surname: Ives fullname: Ives, J organization: Viral Diseases, Roche Discovery Welwyn, 40 Broadwater Road, Welwn Garden City, Herts. AL6 3AY, UK – sequence: 4 givenname: S surname: Elias fullname: Elias, S organization: Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA – sequence: 5 givenname: R surname: Truscon fullname: Truscon, R organization: Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA – sequence: 6 givenname: N surname: Roberts fullname: Roberts, N organization: Viral Diseases, Roche Discovery Welwyn, 40 Broadwater Road, Welwn Garden City, Herts. AL6 3AY, UK – sequence: 7 givenname: A.S surname: Monto fullname: Monto, A.S organization: Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13618588$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12062395$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1rFTEYhYNU7G31JyjZWHQx-uZzMriQUvwoLQjafcjNvKmRmUxNMoX6653be7XQzYWQbJ5zIOc5IgdpSkjISwbvGDD9_sdy6UYoyd8AewvAmWzUE7JipuVNB50-IKv_yCE5KuUXAOi2M8_IIeOguejUiqzPUxhmTH8cvY15LtS7nO9iuqYu0e-84xd0nKurcUo0Jlp_Ik04ZzfGFHtXkF5jQhoLTVOlNbtUxlgr9hs4YM5Yy3PyNLih4Ivde0yuPn-6OvvaXH77cn52etl4Idra-E4ZDUqGsNZCCmGEgy6IgIJrKdFLBmaNrvctCNEbkKH3wfHOByNQKXFMTra1N3n6PWOpdozF4zC4hNNcbMsMX47eCzIjoONKLuCrHTivR-ztTY6jy3f233oL8HoHuOLdEJbv-1geOKGZUcYsnNpyPk-lZAwPCNiNTXtv025UWWD23qbd9H94lPNx62JZOg570x-3aVxGv42YbfERk8c-ZvTV9lPc0_AXz223uQ |
CODEN | ARSRDR |
CitedBy_id | crossref_primary_10_1128_JVI_01226_08 crossref_primary_10_1093_infdis_jiu353 crossref_primary_10_1016_j_antiviral_2007_12_010 crossref_primary_10_1016_S0140_6736_04_16934_1 crossref_primary_10_1128_AAC_47_7_2264_2272_2003 crossref_primary_10_1128_AAC_49_11_4515_4520_2005 crossref_primary_10_1128_JVI_01081_13 crossref_primary_10_1586_14787210_4_5_795 crossref_primary_10_1016_j_virol_2011_02_015 crossref_primary_10_1017_S1462399410001705 crossref_primary_10_1128_JVI_00898_16 crossref_primary_10_1002_ange_200602623 crossref_primary_10_1002_biot_200600159 crossref_primary_10_1086_596312 crossref_primary_10_1038_nrd2175 crossref_primary_10_1016_j_antiviral_2012_07_002 crossref_primary_10_1371_journal_ppat_1002276 crossref_primary_10_1073_pnas_0605134103 crossref_primary_10_1517_13543776_14_8_1153 crossref_primary_10_1016_S0140_6736_13_61209_X crossref_primary_10_1016_j_antiviral_2021_105060 crossref_primary_10_1371_journal_pone_0071230 crossref_primary_10_1093_cid_ciab625 crossref_primary_10_1016_j_rinp_2021_104390 crossref_primary_10_1371_journal_pone_0200849 crossref_primary_10_1016_j_patbio_2010_01_011 crossref_primary_10_1016_j_coviro_2014_04_009 crossref_primary_10_1155_2014_430629 crossref_primary_10_1063_1674_0068_cjcp2110193 crossref_primary_10_1128_JVI_01067_07 crossref_primary_10_1140_epjp_s13360_022_03302_5 crossref_primary_10_1128_JVI_00689_10 crossref_primary_10_1016_S0025_7753_05_72189_8 crossref_primary_10_3201_eid1606_091623 crossref_primary_10_1128_JVI_00373_10 crossref_primary_10_1128_AAC_02628_13 crossref_primary_10_1016_S1473_3099_11_70318_8 crossref_primary_10_1017_S1466252310000137 crossref_primary_10_1111_j_1750_2659_2007_00008_x crossref_primary_10_1177_095632020201300401 crossref_primary_10_1128_AAC_01773_10 crossref_primary_10_7554_eLife_07969 crossref_primary_10_1128_CDLI_11_1_21_28_2004 crossref_primary_10_1126_science_1122947 crossref_primary_10_1093_jac_dkw275 crossref_primary_10_1016_j_antiviral_2011_11_006 crossref_primary_10_3201_eid1909_130724 crossref_primary_10_1097_01_inf_0000144680_39895_ce crossref_primary_10_1016_j_antiviral_2009_09_010 crossref_primary_10_1097_QCO_0b013e3283199797 crossref_primary_10_2165_00151829_200504020_00004 crossref_primary_10_1128_AAC_01699_10 crossref_primary_10_1128_JVI_06901_11 crossref_primary_10_1007_s12250_013_3307_8 crossref_primary_10_1097_MJT_0b013e3180a7206e crossref_primary_10_1186_1471_2334_9_8 crossref_primary_10_1111_irv_12356 crossref_primary_10_2165_11531450_000000000_00000 crossref_primary_10_1093_infdis_jiq067 crossref_primary_10_1242_dmm_007823 crossref_primary_10_1128_AAC_03667_14 crossref_primary_10_1016_j_antiviral_2008_01_003 crossref_primary_10_1016_j_ics_2004_02_060 crossref_primary_10_1016_j_coviro_2011_08_006 crossref_primary_10_1177_135965350701200S04_1 crossref_primary_10_1186_s13567_014_0142_3 crossref_primary_10_1371_journal_pcbi_1002026 crossref_primary_10_1371_journal_pcbi_0030240 crossref_primary_10_3201_eid1502_081031 crossref_primary_10_1177_135965350601100804 crossref_primary_10_1371_journal_ppat_1001022 crossref_primary_10_1016_j_antiviral_2016_11_007 crossref_primary_10_1128_AAC_49_10_4075_4084_2005 crossref_primary_10_1016_j_jcv_2007_10_020 crossref_primary_10_1016_j_virusres_2004_02_035 crossref_primary_10_1002_jmv_20951 crossref_primary_10_1080_02648725_2023_2191081 crossref_primary_10_1080_17460441_2018_1540586 crossref_primary_10_2217_thy_11_79 crossref_primary_10_1016_j_jviromet_2013_02_016 crossref_primary_10_1128_AAC_01339_05 crossref_primary_10_1128_JCM_43_8_4139_4146_2005 crossref_primary_10_1111_j_1440_1843_2008_01404_x crossref_primary_10_1002_anie_200602623 crossref_primary_10_1016_j_jim_2014_03_023 crossref_primary_10_1093_infdis_jiu447 crossref_primary_10_1016_j_vetmic_2009_09_068 crossref_primary_10_1016_j_coi_2011_07_016 crossref_primary_10_1016_S0140_6736_04_16947_X crossref_primary_10_1111_j_1469_0691_2007_01910_x crossref_primary_10_1128_mBio_00396_13 crossref_primary_10_1016_j_antiviral_2018_04_009 crossref_primary_10_3390_v2081510 crossref_primary_10_1098_rstb_2001_1002 crossref_primary_10_3201_eid1201_051068 crossref_primary_10_1098_rsif_2011_0427 crossref_primary_10_1098_rsif_2007_1126 crossref_primary_10_1371_journal_ppat_1009527 crossref_primary_10_1093_jac_dkq012 crossref_primary_10_1016_j_coviro_2011_07_003 crossref_primary_10_1128_AAC_01608_09 crossref_primary_10_1111_irv_12047 crossref_primary_10_1128_AAC_02126_12 crossref_primary_10_1111_irv_12044 crossref_primary_10_1128_AAC_01848_13 crossref_primary_10_1111_irv_12043 |
Cites_doi | 10.1093/clinids/10.1.56 10.1128/AAC.39.11.2583 10.1128/JVI.72.3.2456-2462.1998 10.1086/314713 10.1093/infdis/141.3.351 10.1128/AAC.42.3.640 10.1093/jac/1.suppl_4.35 10.1099/0022-1317-75-10-2835 10.1128/JVI.71.5.3385-3390.1997 10.1016/S0166-3542(00)00103-0 10.1093/infdis/146.6.780 10.1016/0166-0934(89)90004-9 10.1056/NEJM198912213212502 10.1128/AAC.42.12.3234 10.1086/322801 10.1016/S0531-5131(01)00365-X 10.1016/S0166-3542(00)90410-8 10.1006/bbrc.1998.8282 10.1006/viro.1998.9194 10.1093/infdis/164.5.969 10.2165/00003495-199855050-00015 10.1128/AAC.37.7.1473 |
ContentType | Journal Article |
Copyright | 2002 Elsevier Science B.V. 2002 INIST-CNRS |
Copyright_xml | – notice: 2002 Elsevier Science B.V. – notice: 2002 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7U9 H94 7X8 |
DOI | 10.1016/S0166-3542(01)00214-5 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1872-9096 |
EndPage | 111 |
ExternalDocumentID | 12062395 13618588 10_1016_S0166_3542_01_00214_5 S0166354201002145 |
Genre | Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 23M 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AAAJQ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATCM AAXUO ABBQC ABFNM ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CJTIS CNWQP CS3 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMG HVGLF HZ~ IHE J1W KOM LCYCR LUGTX M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SIN SPCBC SSH SSI SSP SSZ T5K TEORI WUQ ZGI ZXP ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS IQODW CGR CUY CVF ECM EIF NPM 7U9 H94 7X8 |
ID | FETCH-LOGICAL-c337t-c9586054ffb6343383a09f3fe32644ec4108beadc7033d804fdcfa29cf83e553 |
IEDL.DBID | .~1 |
ISSN | 0166-3542 |
IngestDate | Fri Jul 11 04:04:02 EDT 2025 Fri Jul 11 10:33:09 EDT 2025 Wed Feb 19 01:32:37 EST 2025 Mon Jul 21 09:16:45 EDT 2025 Tue Jul 01 03:27:37 EDT 2025 Thu Apr 24 22:56:24 EDT 2025 Fri Feb 23 02:25:05 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Resistance Influenza Ferret Transmission Neuraminidase Fissipedia Carnivora Enzyme Orthomyxoviridae Influenzavirus Host virus relation Infection Virus Vertebrata Mammalia Glycosidases Animal Exo-α-sialidase Viral disease Hydrolases Mutation O-Glycosidases |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c337t-c9586054ffb6343383a09f3fe32644ec4108beadc7033d804fdcfa29cf83e553 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 12062395 |
PQID | 18309254 |
PQPubID | 23462 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_71821826 proquest_miscellaneous_18309254 pubmed_primary_12062395 pascalfrancis_primary_13618588 crossref_primary_10_1016_S0166_3542_01_00214_5 crossref_citationtrail_10_1016_S0166_3542_01_00214_5 elsevier_sciencedirect_doi_10_1016_S0166_3542_01_00214_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2002-May |
PublicationDateYYYYMMDD | 2002-05-01 |
PublicationDate_xml | – month: 05 year: 2002 text: 2002-May |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | Antiviral research |
PublicationTitleAlternate | Antiviral Res |
PublicationYear | 2002 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Blick, Sahasrabudhe, McDonald, Owens, Morley, Fenton, McKimm-Breschkin (BIB4) 1998; 246 McKimm-Breschkin, Sahasrabudhe, Blick, McDonald, Colman, Hart, Bethell, Varghese (BIB20) 1998; 72 Li, Liu, Klimov, Subbarao, Perdue, Me, Ji, Woods, Hietala, Bryant (BIB17) 1999; 179 Bantia, Ananth, Horn, Parker, Gulati, Chand, Babu, Air (BIB3) 2000; 46 Herlocher, Elias, Truscon, Harrison, Mindell, Simon, Monto (BIB13) 2001; 184 Truscon, R., Herlocher, M.L., Klimov, A., Monto, A.S., 2001. Generating amantadine- resistant influenza using a ferret model. In: American Society for Virology 20th Annual Meeting Scientific Programs and Abstracts, University of Wisconsin, Madison, WI, 21–25 July 2001, pp. 107. Reuman, Keely, Schiff, James (BIB23) 1989; 24 Carr, Ives, Roberts, Kelly, Lambkin, Oxford, Tai, Mendel, Hayden (BIB6) 2000; 46 Ives, Carr, Roberts, Tai, Mendel, Kelly, Lambkin, Oxford (BIB14) 2000; 18 Kati (BIB16) 1998; 244 Hayden, Belshe, Clover, Hay, Oakes, Soo (BIB11) 1989; 321 Alluwaimi, Smith, Sweet (BIB1) 1994; 75 Ferguson, Mallet (BIB7) 2001; 50 Maassab, Kendal, Abrams, Monto (BIB18) 1982; 146 Ryan, Ticehurst, Dempsey (BIB24) 1995; 39 Squires, Belyavin (BIB26) 1975; 1 Mendel, Tai, Escarpe, Li, Sidwell, Hoffinan, Sweet, Jakeman, Merson, Lacy, Lew, Williams, Zhang, Chen, Bishofberger, Kim (BIB22) 1998; 42 Sweet, Hayden, Jakeman, Grambas, Hay (BIB27) 1991; 164 Andrewes, Glover (BIB2) 1941; 22 Herlocher, M.L., Fenton, R., Merry, A., Elias, S., Monto A.S., 2001a. Influenza resistance to zanamivir generated in ferrets. In: Osherhaus A.D.M.E., Hampson A., Cox N. (Eds.), Options for the Control of Influenza IV. Elsevier Science, pp. 863–878. Matsuyama, Sweet, Collie, Smith (BIB19) 1980; 141 Finney (BIB8) 1952 Hayden, Hay (BIB10) 1992; 176 Waghorn, Goa (BIB31) 1998; 55 McKimm-Breschkin (BIB21) 2000; 47 Smith, Sweet (BIB25) 1988; 10 Toms, Bird, Kingsman, Sweet, Smith (BIB29) 1976; 57 Tai, Escarpe, Sidwell, Willams, Lew, Wu, Kim, Mendel (BIB28) 1998; 42 Gubareva, Robinson, Bethell, Webster (BIB9) 1997; 71 Carr, J., Roberts, N., Tai, C.Y., Wang, M., Mendel, D.B., Kelly, L., Lambkin, R., Oxford, J., 1999. An oseltamivir-treatment selected influenza A: Wuhan/359/95 virus with an e119v mutation in the neuraminidase gene has reduced infectivity in vivo (Abstract). In: Kaiser, L., Couch, R.B., Galasso, G.J., Glezen, W.P., Webster, R.G., Wright, P.F., Hayden, F.G, First International Symposium on Influenza and Other Respiratory Viruses: Summary and Overview: Kapalua, Maui, Hawaii, 4–6 December 1998. Ives, Carr, Roberts, Tai, Mendel, Kelly, Lambkin, Oxford (BIB15) 2000; 18 Woods (BIB32) 1993; 37 Bantia (10.1016/S0166-3542(01)00214-5_BIB3) 2000; 46 Mendel (10.1016/S0166-3542(01)00214-5_BIB22) 1998; 42 Ferguson (10.1016/S0166-3542(01)00214-5_BIB7) 2001; 50 Blick (10.1016/S0166-3542(01)00214-5_BIB4) 1998; 246 Finney (10.1016/S0166-3542(01)00214-5_BIB8) 1952 Hayden (10.1016/S0166-3542(01)00214-5_BIB10) 1992; 176 Squires (10.1016/S0166-3542(01)00214-5_BIB26) 1975; 1 McKimm-Breschkin (10.1016/S0166-3542(01)00214-5_BIB20) 1998; 72 Kati (10.1016/S0166-3542(01)00214-5_BIB16) 1998; 244 Reuman (10.1016/S0166-3542(01)00214-5_BIB23) 1989; 24 Hayden (10.1016/S0166-3542(01)00214-5_BIB11) 1989; 321 Matsuyama (10.1016/S0166-3542(01)00214-5_BIB19) 1980; 141 Ives (10.1016/S0166-3542(01)00214-5_BIB15) 2000; 18 McKimm-Breschkin (10.1016/S0166-3542(01)00214-5_BIB21) 2000; 47 Tai (10.1016/S0166-3542(01)00214-5_BIB28) 1998; 42 Toms (10.1016/S0166-3542(01)00214-5_BIB29) 1976; 57 10.1016/S0166-3542(01)00214-5_BIB5 Gubareva (10.1016/S0166-3542(01)00214-5_BIB9) 1997; 71 10.1016/S0166-3542(01)00214-5_BIB12 Herlocher (10.1016/S0166-3542(01)00214-5_BIB13) 2001; 184 Li (10.1016/S0166-3542(01)00214-5_BIB17) 1999; 179 Carr (10.1016/S0166-3542(01)00214-5_BIB6) 2000; 46 10.1016/S0166-3542(01)00214-5_BIB30 Alluwaimi (10.1016/S0166-3542(01)00214-5_BIB1) 1994; 75 Ives (10.1016/S0166-3542(01)00214-5_BIB14) 2000; 18 Woods (10.1016/S0166-3542(01)00214-5_BIB32) 1993; 37 Sweet (10.1016/S0166-3542(01)00214-5_BIB27) 1991; 164 Ryan (10.1016/S0166-3542(01)00214-5_BIB24) 1995; 39 Maassab (10.1016/S0166-3542(01)00214-5_BIB18) 1982; 146 Waghorn (10.1016/S0166-3542(01)00214-5_BIB31) 1998; 55 Andrewes (10.1016/S0166-3542(01)00214-5_BIB2) 1941; 22 Smith (10.1016/S0166-3542(01)00214-5_BIB25) 1988; 10 |
References_xml | – volume: 244 start-page: 408 year: 1998 end-page: 413 ident: BIB16 article-title: GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains publication-title: Biochem. Biophys. Res. Commun. – volume: 46 start-page: A1 year: 2000 end-page: A90 ident: BIB3 article-title: Generation and Characterisation of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor RWJ-270201 publication-title: Antiviral Res. – volume: 24 start-page: 27 year: 1989 end-page: 34 ident: BIB23 article-title: Assessment of signs of influenza illness in the ferret model publication-title: J. Virol. Methods – volume: 176 start-page: 119 year: 1992 end-page: 130 ident: BIB10 article-title: Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine publication-title: Curr. Top. Microbiol. Immunol. – volume: 72 start-page: 2456 year: 1998 end-page: 2462 ident: BIB20 article-title: Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors publication-title: J. Virol. – volume: 184 start-page: 542 year: 2001 end-page: 546 ident: BIB13 article-title: Ferrets as a transmission model for influenza: sequence changes in the HA1 of type A (H3N2) virus publication-title: J. Infect. Dis. – volume: 47 start-page: 1 year: 2000 end-page: 17 ident: BIB21 article-title: Resistance of influenza viruses to neuraminidase inhibitors—a review publication-title: Antiviral Res. – volume: 246 start-page: 95103 year: 1998 ident: BIB4 article-title: The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en publication-title: Virology – volume: 57 start-page: 37 year: 1976 end-page: 48 ident: BIB29 article-title: The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man publication-title: Br. J. Exp. Pathol. – volume: 18 start-page: 251 year: 2000 ident: BIB14 article-title: An oseltamivir treatment-selected influenza AIN2 virus with a R292K mutation in the neuraminidase gene has reduced infectivity in vivo (P-321) publication-title: J. Clin. Virol. – volume: 164 start-page: 969 year: 1991 end-page: 972 ident: BIB27 article-title: Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets publication-title: J. Infect. Dis. – volume: 37 start-page: 1473 year: 1993 end-page: 1479 ident: BIB32 article-title: 4-Guanidino-2,4-dideoxy-2,3-dehydro- publication-title: Antimicrob. Agents Chemother. – volume: 46 start-page: A59 year: 2000 ident: BIB6 article-title: Virological assessment in vitro and in vivo of an influenza HIN1 virus with a H274Y mutation in the neuraminidase gene (79) publication-title: Antiviral Res. – volume: 50 start-page: A85 year: 2001 ident: BIB7 article-title: An epidemiological model of influenza to investigate the potential transmission of drug resistant virus during community use of antiviral treatment for influenza (165) publication-title: Antiviral Res. – volume: 10 start-page: 56 year: 1988 end-page: 75 ident: BIB25 article-title: Lessons for human influenza from pathogenicity studies with ferrets publication-title: Rev. Infect. Dis. – volume: 1 start-page: 35 year: 1975 end-page: 42 ident: BIB26 article-title: Free contact infection in ferret groups publication-title: J. Antimicrob. Chemother. – volume: 42 start-page: 640 year: 1998 end-page: 646 ident: BIB22 article-title: Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection publication-title: Antimicrob. Agents Chemother. – volume: 39 start-page: 2583 year: 1995 end-page: 2584 ident: BIB24 article-title: GG167 (4-guanidino-2,4-dideoxy2,3-dehydro- publication-title: Antimicrob. Agents Chemother. – volume: 22 start-page: 981 year: 1941 end-page: 997 ident: BIB2 article-title: Spread of infection from the respiratory tract of the ferret. 1. Transmission of influenza a virus publication-title: Br. J. Exp. Pathol. – volume: 141 start-page: 351 year: 1980 end-page: 360 ident: BIB19 article-title: Aspects of virulence in ferrets exhibited by influenza virus recombinants of known genetic constitution publication-title: J. Infect. Dis. – volume: 321 start-page: 1696 year: 1989 end-page: 16702 ident: BIB11 article-title: Emergence and apparent transmission of rimantadine-resistant influenza A virus in families publication-title: New Engl. J. Med. – start-page: 524 year: 1952 end-page: 530 ident: BIB8 publication-title: Statistical Method in Biological Assay – volume: 71 start-page: 3385 year: 1997 end-page: 3390 ident: BIB9 article-title: Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4guanidino-Neu5Ac2en publication-title: J. Virol. – volume: 42 start-page: 323 year: 1998 end-page: 441 ident: BIB28 article-title: Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071 publication-title: Antimicrob. Agents Chemother. – volume: 18 start-page: 255 year: 2000 end-page: 256 ident: BIB15 article-title: An oseltamivir treatment-selected influenza A/Wuhan/359/95 virus with a E119V mutation in the neuraminidase gene has reduced infectivity in vivo (P-330) publication-title: J. Clin. Virol. – reference: Truscon, R., Herlocher, M.L., Klimov, A., Monto, A.S., 2001. Generating amantadine- resistant influenza using a ferret model. In: American Society for Virology 20th Annual Meeting Scientific Programs and Abstracts, University of Wisconsin, Madison, WI, 21–25 July 2001, pp. 107. – volume: 55 start-page: 721 year: 1998 end-page: 725 ident: BIB31 article-title: Zanamivir [Review] publication-title: Drugs – reference: Herlocher, M.L., Fenton, R., Merry, A., Elias, S., Monto A.S., 2001a. Influenza resistance to zanamivir generated in ferrets. In: Osherhaus A.D.M.E., Hampson A., Cox N. (Eds.), Options for the Control of Influenza IV. Elsevier Science, pp. 863–878. – volume: 146 start-page: 780 year: 1982 end-page: 790 ident: BIB18 article-title: Evaluation of a cold-recombinant influenza virus vaccine in ferrets publication-title: J. Infect. Dis. – reference: Carr, J., Roberts, N., Tai, C.Y., Wang, M., Mendel, D.B., Kelly, L., Lambkin, R., Oxford, J., 1999. An oseltamivir-treatment selected influenza A: Wuhan/359/95 virus with an e119v mutation in the neuraminidase gene has reduced infectivity in vivo (Abstract). In: Kaiser, L., Couch, R.B., Galasso, G.J., Glezen, W.P., Webster, R.G., Wright, P.F., Hayden, F.G, First International Symposium on Influenza and Other Respiratory Viruses: Summary and Overview: Kapalua, Maui, Hawaii, 4–6 December 1998. – volume: 75 start-page: 2835 year: 1994 end-page: 2840 ident: BIB1 article-title: Role of surface glycoproteins in influenza virus pyrogenicity publication-title: J. Gen. Virol. – volume: 179 start-page: 1132 year: 1999 end-page: 1138 ident: BIB17 article-title: Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses publication-title: J. Infect. Dis. – volume: 50 start-page: A85 year: 2001 ident: 10.1016/S0166-3542(01)00214-5_BIB7 article-title: An epidemiological model of influenza to investigate the potential transmission of drug resistant virus during community use of antiviral treatment for influenza (165) publication-title: Antiviral Res. – volume: 10 start-page: 56 year: 1988 ident: 10.1016/S0166-3542(01)00214-5_BIB25 article-title: Lessons for human influenza from pathogenicity studies with ferrets publication-title: Rev. Infect. Dis. doi: 10.1093/clinids/10.1.56 – volume: 39 start-page: 2583 year: 1995 ident: 10.1016/S0166-3542(01)00214-5_BIB24 article-title: GG167 (4-guanidino-2,4-dideoxy2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.39.11.2583 – volume: 72 start-page: 2456 year: 1998 ident: 10.1016/S0166-3542(01)00214-5_BIB20 article-title: Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors publication-title: J. Virol. doi: 10.1128/JVI.72.3.2456-2462.1998 – volume: 18 start-page: 251 year: 2000 ident: 10.1016/S0166-3542(01)00214-5_BIB14 article-title: An oseltamivir treatment-selected influenza AIN2 virus with a R292K mutation in the neuraminidase gene has reduced infectivity in vivo (P-321) publication-title: J. Clin. Virol. – volume: 179 start-page: 1132 year: 1999 ident: 10.1016/S0166-3542(01)00214-5_BIB17 article-title: Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses publication-title: J. Infect. Dis. doi: 10.1086/314713 – volume: 141 start-page: 351 year: 1980 ident: 10.1016/S0166-3542(01)00214-5_BIB19 article-title: Aspects of virulence in ferrets exhibited by influenza virus recombinants of known genetic constitution publication-title: J. Infect. Dis. doi: 10.1093/infdis/141.3.351 – volume: 46 start-page: A1 year: 2000 ident: 10.1016/S0166-3542(01)00214-5_BIB3 article-title: Generation and Characterisation of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor RWJ-270201 publication-title: Antiviral Res. – volume: 42 start-page: 640 year: 1998 ident: 10.1016/S0166-3542(01)00214-5_BIB22 article-title: Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.42.3.640 – volume: 1 start-page: 35 issue: 4 Suppl. year: 1975 ident: 10.1016/S0166-3542(01)00214-5_BIB26 article-title: Free contact infection in ferret groups publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/1.suppl_4.35 – volume: 75 start-page: 2835 year: 1994 ident: 10.1016/S0166-3542(01)00214-5_BIB1 article-title: Role of surface glycoproteins in influenza virus pyrogenicity publication-title: J. Gen. Virol. doi: 10.1099/0022-1317-75-10-2835 – volume: 71 start-page: 3385 year: 1997 ident: 10.1016/S0166-3542(01)00214-5_BIB9 article-title: Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4guanidino-Neu5Ac2en publication-title: J. Virol. doi: 10.1128/JVI.71.5.3385-3390.1997 – volume: 47 start-page: 1 year: 2000 ident: 10.1016/S0166-3542(01)00214-5_BIB21 article-title: Resistance of influenza viruses to neuraminidase inhibitors—a review publication-title: Antiviral Res. doi: 10.1016/S0166-3542(00)00103-0 – volume: 146 start-page: 780 year: 1982 ident: 10.1016/S0166-3542(01)00214-5_BIB18 article-title: Evaluation of a cold-recombinant influenza virus vaccine in ferrets publication-title: J. Infect. Dis. doi: 10.1093/infdis/146.6.780 – volume: 24 start-page: 27 year: 1989 ident: 10.1016/S0166-3542(01)00214-5_BIB23 article-title: Assessment of signs of influenza illness in the ferret model publication-title: J. Virol. Methods doi: 10.1016/0166-0934(89)90004-9 – volume: 321 start-page: 1696 year: 1989 ident: 10.1016/S0166-3542(01)00214-5_BIB11 article-title: Emergence and apparent transmission of rimantadine-resistant influenza A virus in families publication-title: New Engl. J. Med. doi: 10.1056/NEJM198912213212502 – start-page: 524 year: 1952 ident: 10.1016/S0166-3542(01)00214-5_BIB8 – ident: 10.1016/S0166-3542(01)00214-5_BIB30 – volume: 176 start-page: 119 year: 1992 ident: 10.1016/S0166-3542(01)00214-5_BIB10 article-title: Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine publication-title: Curr. Top. Microbiol. Immunol. – volume: 42 start-page: 323 year: 1998 ident: 10.1016/S0166-3542(01)00214-5_BIB28 article-title: Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.42.12.3234 – volume: 184 start-page: 542 issue: 5 year: 2001 ident: 10.1016/S0166-3542(01)00214-5_BIB13 article-title: Ferrets as a transmission model for influenza: sequence changes in the HA1 of type A (H3N2) virus publication-title: J. Infect. Dis. doi: 10.1086/322801 – ident: 10.1016/S0166-3542(01)00214-5_BIB12 doi: 10.1016/S0531-5131(01)00365-X – volume: 18 start-page: 255 year: 2000 ident: 10.1016/S0166-3542(01)00214-5_BIB15 article-title: An oseltamivir treatment-selected influenza A/Wuhan/359/95 virus with a E119V mutation in the neuraminidase gene has reduced infectivity in vivo (P-330) publication-title: J. Clin. Virol. – volume: 46 start-page: A59 year: 2000 ident: 10.1016/S0166-3542(01)00214-5_BIB6 article-title: Virological assessment in vitro and in vivo of an influenza HIN1 virus with a H274Y mutation in the neuraminidase gene (79) publication-title: Antiviral Res. doi: 10.1016/S0166-3542(00)90410-8 – volume: 22 start-page: 981 year: 1941 ident: 10.1016/S0166-3542(01)00214-5_BIB2 article-title: Spread of infection from the respiratory tract of the ferret. 1. Transmission of influenza a virus publication-title: Br. J. Exp. Pathol. – volume: 244 start-page: 408 year: 1998 ident: 10.1016/S0166-3542(01)00214-5_BIB16 article-title: GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1998.8282 – volume: 57 start-page: 37 year: 1976 ident: 10.1016/S0166-3542(01)00214-5_BIB29 article-title: The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man publication-title: Br. J. Exp. Pathol. – volume: 246 start-page: 95103 year: 1998 ident: 10.1016/S0166-3542(01)00214-5_BIB4 article-title: The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en publication-title: Virology doi: 10.1006/viro.1998.9194 – ident: 10.1016/S0166-3542(01)00214-5_BIB5 – volume: 164 start-page: 969 year: 1991 ident: 10.1016/S0166-3542(01)00214-5_BIB27 article-title: Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets publication-title: J. Infect. Dis. doi: 10.1093/infdis/164.5.969 – volume: 55 start-page: 721 year: 1998 ident: 10.1016/S0166-3542(01)00214-5_BIB31 article-title: Zanamivir [Review] publication-title: Drugs doi: 10.2165/00003495-199855050-00015 – volume: 37 start-page: 1473 year: 1993 ident: 10.1016/S0166-3542(01)00214-5_BIB32 article-title: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.37.7.1473 |
SSID | ssj0006798 |
Score | 2.0471866 |
Snippet | A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 99 |
SubjectTerms | Animals Biological and medical sciences Disease Models, Animal Disease Transmission, Infectious DNA, Viral Ferret Ferrets - virology Fever Fundamental and applied biological sciences. Psychology Genetics Influenza Influenza A virus - enzymology Influenza A virus - genetics Influenza virus Male Microbiology Mutation Nasal Lavage Fluid - virology Neuraminidase Neuraminidase - genetics Orthomyxoviridae Infections - transmission Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains Resistance Sequence Analysis, DNA Transmission Viral Load Virology |
Title | Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets |
URI | https://dx.doi.org/10.1016/S0166-3542(01)00214-5 https://www.ncbi.nlm.nih.gov/pubmed/12062395 https://www.proquest.com/docview/18309254 https://www.proquest.com/docview/71821826 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hEFUlhIA-2JZufeihPYTNxnbiHBECLUXl0FKJm-U4thSpZFebLBIc-O2dibNdOKyQerXsSeQZz3yjeQF8sTT0LVU8ynKFDopJaMxLQmk71pZJLk0Run1epZPf4vuNvNmA02UtDKVV9ro_6PROW_cro_42R7OqGv1CsILWUlA4lxp_UaG5EBlJ-fHjKs2Dogyhv3ca0e5VFU-g0C1-jcffOiKRXGefdmamwVvzYdzFejza2aXzPdjtASU7Cf-8DxuuPoDtMGLy_gBe_eiD52-guAgDSR4Mu6vmi4ZZM59TlRMzNfuZ5Mklu12EyDyraobIkFG3S0PdR0o0dgxlzbGqYfW0ZS3ZuNuqRcBKm72jjN_mLVyfn12fTqJ-xEJkOc_ayOZSoUMjvC9SLshdNXHuuXecgJKzYhyrAoXNomLgpYqFL603SW694k5K_g4262ntDoH5MjNF5pCe84I7JBwnRpbSZxlCoHE2ALG8V2379uM0BeOPfpJnlqaa2KHjse7YoeUAjv8dm4X-Gy8dUEum6WeCpNFGvHR0-IzJqw_yFGGNUgP4vOS6xldIoRVTu-mi0agY4xx97fU7EANQs_x0AO-DuKyoJzFi0Fx--P8__wivuyk1XSLmEWy284X7hGCpLYbdaxjC1snF5eTqL9QwC1I |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VVgUkhGhpYYG2PnCAQ7rZ2E6cI6pabenHARapN8txbClSm11tskhw4LczE2dZelhV6tWyJ5FnPPOsGc8D-GiJ9C1VPMpyhRcUkxDNS0JlO9aWSS5NEbp9XqfjH-LrjbzZgJPlWxgqq-x9f_DpnbfuR4b9bg5nVTX8jmAFo6WgdC41_pJPYEvg8SUag-M_qzoPSjOEBt9pRNNXz3iCiG7wUzz63EmJ5LoA9WJmGtw2H_gu1gPSLjCdvYKXPaJkX8JP78CGq3dhO3BM_tqFp1d99vw1FOeBkeS3YT-r-aJh1szn9MyJmZp9S_Lkgt0tQmqeVTVDaMio3aWh9iMlRjuGxuZY1bB62rKWgtxd1SJipcneUclvsweTs9PJyTjqORYiy3nWRjaXCm80wvsi5YLuqybOPfeOE1JyVoxiVaC1WfQMvFSx8KX1JsmtV9xJyfdhs57W7i0wX2amyBzKc15wh4LjxMhS-ixDDDTKBiCW-6pt33-caDBu9X-FZmmqSR06HulOHVoO4PjfsllowPHQArVUmr5nSRqDxENLD-8pefVBniKuUWoAR0utazyGlFsxtZsuGo2eMc7xsr1-BoIA6pafDuBNMJeV9CRGEJrLd4__8yN4Np5cXerL8-uL9_C8o6zpqjI_wGY7X7gDRE5tcdidjL_WvQzg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza+virus+carrying+an+R292K+mutation+in+the+neuraminidase+gene+is+not+transmitted+in+ferrets&rft.jtitle=Antiviral+research&rft.au=Herlocher%2C+M.L&rft.au=Carr%2C+J&rft.au=Ives%2C+J&rft.au=Elias%2C+S&rft.date=2002-05-01&rft.issn=0166-3542&rft.volume=54&rft.issue=2&rft.spage=99&rft.epage=111&rft_id=info:doi/10.1016%2FS0166-3542%2801%2900214-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S0166_3542_01_00214_5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0166-3542&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0166-3542&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0166-3542&client=summon |